Gestational Diabetes Trial Data from Morocco

A 2020 cluster randomized controlled trial in two Moroccan districts analyzed data from 210 recruited pregnant women to evaluate a primary care intervention for gestational diabetes. The study assessed outcomes including birthweight, maternal weight gain, glucose control, and pregnancy complications. It was conducted by Bettina Utz and registered under NCT02979756.

Use Cases

• Compare birthweight and macrosomia proportions between intervention and control groups to measure the intervention's effect on newborn outcomes.
• Analyze maternal weight gain and fasting blood sugar values to assess the impact of nutrition and exercise counseling on glucose balance.
• Examine follow-up intervals and complication rates to evaluate the effectiveness of primary health care management for gestational diabetes.

Strengths

• Data originates from a registered clinical trial (NCT02979756) with a defined protocol and statistical analysis.
• Study reports a 23.7% GDM prevalence in Marrakech and quantifies intervention effects, such as a 147-gram lower mean birthweight.

Limitations

• Limited sample size of 210 women from only two districts, reducing generalizability.
• Potential for Hawthorn-effect bias at control sites, which may have underestimated the true effect size.

Provenance

Source

Dryad

Collection Method

Cluster randomized controlled trial conducted in 10 health centers across two districts in Morocco.

Time Range

null

Freshness

null

Geography

Two districts in Morocco